ALKBH5‐Driven m6A Demethylation Boosts Inflammation and Autophagy in LPS‐Stimulated Macrophages
Immunity, Inflammation and Disease · 2026-03 · 14 (3)
DOI: 10.1002/iid3.70348 ↗Kurz gefasst
Fachartikel in der Zeitschrift Immunity, Inflammation and Disease, online erschienen am 16.03.2026. Verfasst von Gui Wang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Critical Care Medicine, The First People's Hospital of Changzhou, The Third Affiliated Hospital of Soochow University, Changzhou, China. Hauptthemen laut MEDLINE: Autophagy, AlkB Homolog 5, RNA Demethylase, Macrophages, Alveolar, Inflammation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Top Talent of Changzhou "The 14th 5-Year Plan" High-Level Health Talents Training Project, The Science and Technology Program of Changzhou Health Commission, Changzhou Sci&Tech Program.
Abstract (Originalsprache)
Purpose
Acute Respiratory Distress Syndrome (ARDS) remains a critical health threat with limited pharmacological treatments. This study investigates the role of the N 6 ‐methyladenosine (m 6 A) demethylase AlkB homolog 5 (ALKBH5) in alveolar macrophages and its subsequent impact on inflammation and autophagy during ARDS pathogenesis.
Methods
Primary mouse alveolar macrophages were stimulated with Lipopolysaccharide (LPS) and transfected with ALKBH5 knockdown or overexpression plasmids. Global m6A levels were assessed via Dot Blot, while m 6 A modification of the target gene ULK1 was analyzed using MeRIP‐qPCR. Macrophage polarization, migration, and autophagy (LC3‐II/p62 flux) were evaluated in vitro . The therapeutic potential of ALKBH5 downregulation was validated in an LPS‐induced murine ARDS model through lung histology, cytokine analysis (ELISA), and microvascular permeability assessments.
Results
ALKBH5 was found to be a critical regulator of m 6 A methylation in alveolar macrophages. LPS stimulation decreased m 6 A modification of ULK1 mRNA, a process reversed by ALKBH5 downregulation. ALKBH5 knockdown significantly suppressed LPS‐induced autophagy by reducing autophagosome formation and inhibited M1 pro‐inflammatory polarization. In vivo, ALKBH5 downregulation significantly mitigated lung tissue damage, reduced pulmonary edema, and lowered levels of pro‐inflammatory cytokines, including IL‐1β, TNF‐α, and IL‐17.
Conclusions
Our findings demonstrate that ALKBH5‐driven m 6 A demethylation of ULK1 exacerbates ARDS by promoting macrophage autophagy and pro‐inflammatory responses. These results suggest that targeting ALKBH5 may disrupt pathogenic m6A demethylation, offering a novel therapeutic strategy for mitigating ARDS progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Critical Care Medicine, The First People's Hospital of Changzhou, The Third Affiliated Hospital of Soochow University, Changzhou, China.
ORCID-Profile: Shujun Zhou
Förderung
- The Top Talent of Changzhou "The 14th 5-Year Plan" High-Level Health Talents Training Project
- The Science and Technology Program of Changzhou Health Commission
- Changzhou Sci&Tech Program
Zitieren
APA
Wang, G., Zhou, T., & Zhou, S. (2026). ALKBH5‐Driven m6A Demethylation Boosts Inflammation and Autophagy in LPS‐Stimulated Macrophages. Immunity, Inflammation and Disease, 14(3). https://doi.org/10.1002/iid3.70348
Vancouver
Wang G, Zhou T, Zhou S. ALKBH5‐Driven m6A Demethylation Boosts Inflammation and Autophagy in LPS‐Stimulated Macrophages. Immunity, Inflammation and Disease. 2026;14(3). doi:10.1002/iid3.70348
BibTeX
@article{Wang2026,
author = {Wang, Gui and Zhou, Ting and Zhou, Shujun},
title = {ALKBH5‐Driven m6A Demethylation Boosts Inflammation and Autophagy in LPS‐Stimulated Macrophages},
journal = {Immunity, Inflammation and Disease},
year = {2026},
volume = {14},
number = {3},
doi = {10.1002/iid3.70348}
}
EUVIMED